Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tony Loughman
Observed names:
A. LOUGHMAN,
Anthony Loughman,
T Loughman,
T. Loughman
Observed institutions:
University College Dublin,
Royal College of Surgeons in Ireland,
Lund University,
Trinity College Dublin,
OncoMark (Ireland),
St. Vincent's University Hospital,
Skåne University Hospital
show all 7
ORCID:
0000-0002-4632-7450
Observed ORCID:
0000-0002-4632-7450
OpenAlex ID:
A5041465916
Works
53
Awards
1
A NovelStaphylococcus aureusBiofilm Phenotype Mediated by the Fibronectin-Binding Proteins, FnBPA and FnBPB
2008
·
Eoghan O'Neill
, Clarissa Pozzi
, et al.
·
Journal of Bacteriology
·
513
Fibronectin‐binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcγRIIa receptor
2005
·
J. Ross Fitzgerald
, Anthony Loughman
, et al.
·
Molecular Microbiology
·
204
PDF
Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A
2005
·
Anthony Loughman
, J. Ross Fitzgerald
, et al.
·
Molecular Microbiology
·
181
PDF
Clumping factor A ofStaphylococcus aureusinhibits phagocytosis by human polymorphonuclear leucocytes
2006
·
Judy Higgins
, Anthony Loughman
, et al.
·
FEMS Microbiology Letters
·
135
PDF
Fibrinogen and elastin bind to the same region within the A domain of fibronectin binding protein A, an MSCRAMM of Staphylococcus aureus
2006
·
Fiona M. Keane
, Anthony Loughman
, et al.
·
Molecular Microbiology
·
119
PDF
Molecular Basis for Staphylococcus aureus –Mediated Platelet Aggregate Formation Under Arterial Shear In Vitro
2007
·
Steven W. Kerrigan
, Niamh Clarke
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
106
PDF
Elucidating the role of Staphylococcus epidermidis serine–aspartate repeat protein G in platelet activation
2009
·
M.P. BRENNAN
, A. LOUGHMAN
, et al.
·
Journal of Thrombosis and Haemostasis
·
95
PDF
Both Complement- and Fibrinogen-Dependent Mechanisms Contribute to Platelet Aggregation Mediated by Staphylococcus aureus Clumping Factor B
2007
·
Helen Miajlovic
, Anthony Loughman
, et al.
·
Infection and Immunity
·
77
Capsular Polysaccharide Masks Clumping Factor A–Mediated Adherence ofStaphylococcus aureusto Fibrinogen and Platelets
2007
·
Allison L. Risley
, Anthony Loughman
, et al.
·
The Journal of Infectious Diseases
·
56
PDF
The Role ofStaphylococcus aureusAdhesins in the Pathogenesis of Ventricular Assist Device–Related Infections
2006
·
Carlos Arrecubieta
, Tomohiro Asai
, et al.
·
The Journal of Infectious Diseases
·
56
Sequence diversity in the A domain of Staphylococcus aureusfibronectin-binding protein A
2008
·
Anthony Loughman
, Tara Sweeney
, et al.
·
BMC Microbiology
·
55
PDF
Added Value of Soluble Tumor Necrosis Factor-α Receptor 1 as a Biomarker of ESRD Risk in Patients With Type 1 Diabetes
2014
·
Carol Forsblom
, John Moran
, et al.
·
Diabetes Care
·
51
Validation of the OncoMasTR Risk Score in Estrogen Receptor–Positive/HER2-Negative Patients: A TransATAC study
2019
·
Richard Buus
, Ivana Sestak
, et al.
·
Clinical Cancer Research
·
15
PDF
Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer
2022
·
Tony Loughman
, Stephen Barron
, et al.
·
Clinical Chemistry
·
8
PDF
Prognostic value of the 6-gene OncoMasTR test in hormone receptor–positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors
2021
·
Seodhna M. Lynch
, Niamh M. Russell
, et al.
·
European Journal of Cancer
·
5
PDF
The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor–Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8
2021
·
Martin Filipits
, Margaretha Rudas
, et al.
·
Clinical Cancer Research
·
4
Analytical validation of OncoMasTR, a multigene test for predicting risk of distant recurrence in hormone receptor-positive early stage breast cancer
2018
·
T. Loughman
, A. Chan-Ju Wang
, et al.
·
Annals of Oncology
·
4
Validation of a membrane touch biosensor for the qualitative detection of IgG class antibodies to herpes simplex virus type 2
2017
·
Tony Loughman
, Baljit Singh
, et al.
·
The Analyst
·
4
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer
2023
·
Agnieszka Krzyzanowska
, Stephen Barron
, et al.
·
European Urology Focus
·
3
PDF
Additional prognostic value of OncoMasTR multigene prognostic signature to clinicopathological information in patients with HR-positive, HER2-negative, lymph node-negative breast cancer from the TAILORx Tissue Bank, Ireland.
2019
·
Darran O'Connor
, Catherine Margaret Kelly
, et al.
·
Journal of Clinical Oncology
·
3
Evaluation of the OncoMasTR prognostic signature in postmenopausal women with primary ER-positive breast cancer.
2018
·
Ivana Sestak
, Richard Buus
, et al.
·
Journal of Clinical Oncology
·
2
PDF
Comparison of the prognostic performance between OncoMasTR and OncotypeDX multigene signatures in hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.
2018
·
Catherine Margaret Kelly
, John Crown
, et al.
·
Journal of Clinical Oncology
·
1
Ip31-22 Clinical Utility and Prognostic Value of a Six-gene Signature for Aggressive Prostate Cancer Among Clinically Low Risk Patients
2026
·
Anders Bjartell
, Agnieszka Krzyzanowska
, et al.
·
The Journal of Urology
Prognostic value and clinical utility of a six-gene signature for aggressive prostate cancer among clinically low or intermediate risk patients.
2026
·
Agnieszka Krzyzanowska
, Stephen Barron
, et al.
·
Journal of Clinical Oncology
PDF
Clinical validation of a biopsy‐based six‐gene signature prognostic for aggressive prostate cancer
2024
·
Agnieszka Krzyzanowska
, Debra F. Higgins
, et al.
·
BJUI Compass
PDF
Show more works
View as search
Works count:
53
Citation count:
1,697
H-index:
13
I10-index:
13
Year
Topic
Type
